The race continues, firms with backing, but nothing on the market yet, and a while before a product will show up as research and development continue. A big chunk of change from Intel doesn't hurt matters either for Pacific Biosciences. VisiGen Biotechnologies is also entered in the X-Prize competition, as I have mentioned here quite frequently about the Polonator, who is also competing.
Illumina (ILMN), Applied Biosystems (ABI), and Helicos BioSciences (HLCS) have already gone public.
These 3 are still work and technology in progress and do not have a product on the market yet. BD
(Fortune Magazine) -- It took the Human Genome Project $3 billion and 13 years to map the first genome and reduce it to a chemical code six billion letters long. Today, with faster computers and improved techniques, a research laboratory can sequence your DNA in about six weeks at a cost of $100,000 to $300,000.
Now a startup called Pacific Biosciences vows to do the job in 15 minutes for less than $1,000. The Menlo Park, Calif., outfit says that by 2013 it will have a microwave-oven-sized machine on the market that could bring genomics to the masses.
CEO Hugh Martin is confident that PacBio, which is backed by blue-chip venture capital firms including Mohr Davidow and Kleiner Perkins, will be the first to get a fast and cheap product on the market.